SCHEMBL17827994

SCHEMBL17827994

COC(=O)C(C)c1ccc(C)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 2/20 0.36
CCR1 P32246 1/20 0.36
CCR5 P51681 1/20 0.36
CCR8 P51685 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MT-CO2 P00403 1/20 0.36
CNR1 P21554 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NPC1 O15118 3/20 0.36
HPGD P15428 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
XIAP P98170 1/20 0.36
BIRC2 Q13490 1/20 0.36
MITF O75030 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17820225 0.83 RAB9A (0.43) RAB9AMAPTKMT2AMEN1KDM4E
SCHEMBL27668674 0.82 RAB9A (0.48) RAB9AMAPTKDM4EALDH1A1CCR1
SCHEMBL9274644 0.81 PTGS1 (0.35) KMT2AMEN1KDM4EALDH1A1HSD17B10
SCHEMBL18148764 0.81 PTK2 (0.44) RAB9AKMT2AMEN1TDP1NPC1
SCHEMBL18595225 0.81 RAB9A (0.42) RAB9AMAPTKMT2AMEN1KDM4E
SCHEMBL23982614 0.81 KDM4E (0.41) RAB9AMAPTKMT2AMEN1KDM4E
SCHEMBL31240136 0.80 MAPT (0.43) RAB9AMAPTKDM4EALDH1A1CCR1
SCHEMBL1851645 0.79 ADRA2A (0.42) RAB9AMAPTKMT2AMEN1KDM4E
SCHEMBL6189387 0.78 PTGS2 (0.44) MAPTKMT2AALDH1A1GAAPTGS1
SCHEMBL1028262 0.74 CYP1A2 (0.57) RAB9AKMT2AMEN1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9586951-B2 Morpholine derivative or salt thereof FUJIFILM CORPORATION (JP) 2017-03-07 US disclosed
US-9586951-B2 Morpholine derivative or salt thereof FUJIFILM CORPORATION (JP) 2017-03-07 US disclosed
EP-3042900-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF Fujifilm Corporation (JP) 2016-07-13 EP disclosed
US-20160168139-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2016-06-16 US disclosed
US-20160168139-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168139-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF PRMT7, RBBP7, RER1 RAB9A 757/4885MAPT 3669/4885KMT2A 1128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.